Tag Archive for: mRNA

Highlighting the need for a therapeutic solution in Stress Urinary Incontinence during World Continence Week

/in

Optimum Strategic Communications is pleased to support Versameb during World Continence Week, a company raising awareness of the high unmet medical need of patients suffering with Stress Urinary Incontinence (SUI) and continence related issues which impacts the lives of millions of patients worldwide. Versameb’s Chief Executive Officer, Klaas Zuideveld to present on the Company’s proprietary […]

Read more

eTheRNA: New agreement paves way for development of first African-owned COVID-19 vaccine

/in

A year after the establishment of the mRNA Vaccine Technology Transfer Hub, Afrigen and Univercells enter a new agreement to develop the first African-own COVID-19 vaccine  CAPE TOWN (SOUTH AFRICA) & BRUSSELS (BELGIUM), JUNE 21, 2022 – One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two of the […]

Read more

The promise of mRNA therapeutics in producing the first regenerative treatment for SUI

/in

Article by Dr Roger Dmochowski, Professor of Urology & Advisory Board Member of Versameb

Read more

Versameb CEO Klaas Zuideveld to Present at the RNA Leaders World Congress

/in

Presentation demonstrates lead therapeutic candidate VMB-100 has the potential to address the unmet medical needs of patients suffering from Stress Urinary Incontinence Versameb AG (“Versameb”), a pre-clinical stage company focused on discovering and developing innovative RNA-based therapeutics, today announces that its leadership team will be attending the RNA Leaders World Congress, taking place on the 16-17th […]

Read more

Touchlight and Versameb announce GMP manufacturing supply agreement

/in

Versameb moves forward with its lead asset towards clinical development with an Innovative synthetic doggybone DNA technology which increases quality and yield of mRNA therapeutics production Touchlight, a biotechnology company pioneering enzymatic DNA production to enable the genetic medicine revolution, today announces a development and manufacturing pipeline agreement with Versameb AG, an innovative pre-clinical stage […]

Read more